VIR

VIR EBITDA Growth

51.38%TTM

Period ending:

VIR TTM EBITDA YoY %%
VIR TTM EBITDA YoY %902.65%-287.56%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

VIR ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Vir Biotechnology Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
51.3817%
20.9461%
10.313%
3.2162%
-12.0247%
0.788%
17.1496%
18.9915%
-83.1347%
-104.0118%
-172.3739%
-141.2659%
-120.0265%
-117.3359%
87.3966%
787.471%
573.4604%
535.6063%
260.3214%
2.9054%
-44.073%
-82.5301%
-66.7968%
-72.5526%
-58.6822%
-75.2093%
-47.964%

Compare ebitda growth

All VIR financial metrics · VIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.